Skip to Main content Skip to Navigation
Journal articles

Evaluation of commercial anti-SARS-CoV-2 antibody assays and comparison of standardized titers in vaccinated healthcare workers.

Abstract : With the availability of vaccines, commercial assays detecting anti-SARS-CoV-2 antibodies (Ab) evolved towards quantitative assays directed to the spike glycoprotein or its receptor binding domain (RBD). The main objective of the present study was to compare the Ab titers obtained with quantitative commercial binding Ab assays, after 1 dose (convalescent individuals) or 2 doses (naïve individuals) of vaccine, in healthcare workers (HCW). Antibody titers were measured in 255 sera (from 150 HCW) with 5 quantitative immunoassays (Abbott RBD IgG II quant, bioMérieux RBD IgG, DiaSorin Trimeric spike IgG, Siemens Healthineers RBD IgG, Wantai RBD IgG). One qualitative total antibody anti RBD detection assay (Wantai) was used to detect previous infection before vaccination. The results are presented in binding Ab units (BAU)/mL after application, when possible, of a conversion factor provided by the manufacturers and established from a World Health Organization (WHO) internal standard. There was a 100% seroconversion with all assays evaluated after two doses of vaccine. With assays allowing BAU/ml correction, Ab titers were correlated (Pearson correlation coefficient, ρ, range: 0.85-0.94). The titer differences varied by a mean of 10.6% between Siemens and bioMérieux assays to 60.9% between Abbott and DiaSorin assays. These results underline the importance of BAU conversion for the comparison of Ab titer obtained with the different quantitative assays. However, significant differences persist, notably, between kits detecting Ab against the different antigens. A true standardization of the assays would be to include the International Standard in the calibration of each assays to express the results in IU/mL
Document type :
Journal articles
Complete list of metadata

https://hal.archives-ouvertes.fr/hal-03453530
Contributor : Muriel Rabilloud Connect in order to contact the contributor
Submitted on : Sunday, November 28, 2021 - 2:56:55 PM
Last modification on : Monday, June 20, 2022 - 4:19:06 PM

Links full text

Identifiers

Citation

Kahina Saker, Vanessa Escuret, Virginie Pitiot, Amélie Massardier-Pilonchéry, Stéphane Paul, et al.. Evaluation of commercial anti-SARS-CoV-2 antibody assays and comparison of standardized titers in vaccinated healthcare workers.. Journal of Clinical Microbiology, American Society for Microbiology, 2021, ⟨10.1128/JCM.01746-21⟩. ⟨hal-03453530⟩

Share

Metrics

Record views

21